The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1476
August 31, 2015
View Complete Issue         Table of Contents 2019 
Onexton Gel for Acne
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Onexton Gel for Acne
August 31, 2015 (Issue: 1476)
The FDA has approved another fixed combination of the antibiotic clindamycin phosphate and the oxidizing agent benzoyl peroxide (Onexton Gel 1.2%/3.75% – Valeant) for topical treatment of acne in patients ≥12 years old. Topical products...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Onexton Gel for Acne
Article code: 1476d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.